In the BioHarmony Drug Report Database

"Preview" Icon

Indinavir

Crixivan (indinavir) is a small molecule pharmaceutical. Indinavir was first approved as Crixivan on 1996-03-13. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections. Crixivan’s patent is valid until 2021-02-10 (FDA).

 

Trade Name

 

Crixivan
 

Common Name

 

indinavir
 

ChEMBL ID

 

CHEMBL115
 

Indication

 

acquired immunodeficiency syndrome, hiv infections
 

Drug Class

 

Antivirals: HIV protease inhibitors (saquinavir type)

Image (chem structure or protein)

Indinavir structure rendering